Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| ivci:metrics [2023/09/03 13:01] – ↷ Links adapted because of a move operation fkaag | ivci:metrics [2024/04/02 15:52] (current) – fkaag | ||
|---|---|---|---|
| Line 3: | Line 3: | ||
| The metrics identified so far are that a code system should be: | The metrics identified so far are that a code system should be: | ||
| - | * [[Complete]] | + | * [[Complete]], that is able to represent any administered vaccine. Completeness implies also that code system is: |
| - | * [[Precise]] | + | * able to represent vaccines administered anywhere in the world. |
| - | * [[Informative]] | + | * able to represent vaccines administered anytime in the past (historical) |
| - | * [[Non-specific]] | + | * able to represent vaccines that are only partially described (non-specific) |
| - | * [[Historical]] | + | * [[Precise]], that is able to discriminate across different vaccines. |
| - | * [[Mappable]] | + | |
| - | * [[license]] | + | |
| - | * [[Maintained]] | + | |
| - | * [[Tolerant]] (inclusive of written trails) | + | |
| - | * [[Inclusive]] (inclusive of digital trails) | + | |
| + | Adopting the NUVA ontology as the common transcription for other code systems provides further benefits that are no longer needed to embed within each code system : | ||
| + | * The ability to correlate information bound to other code systems, be it NUVA itself (valences and target diseases), pharmaceutical codes (detailed composition, | ||
| + | * The ability to transcribe to the code system used for any preexisting tool. | ||
| + | |||
| + | Other characteristics relate more to the management of the code system: | ||
| + | * a liberal [[license]] | ||
| + | * a managed and efficient [[maintenance]] process | ||